GBA1 and Parkinson disease: Clinically, our previous studies have demonstrated that lysosomal lipid hydrolase activities in the brain, including GBA1, are reduced in human and animal aging, and further reductions in hydrolase activities in PD lead to glycolipid substrate accumulation [19,20,44].